Oncostellae to receive biotechnology funds
Oncostellae dará entrada a más fondos biotecnológicos
Intel ID : 234440
Synopsis |
Oncostellae is preparing to receive funds specialized in biotechnology to finance the preclinical phase of drugs for the treatment of hematologic and prostate cancer, as published by newspaper Expansión on 4 March 2016, citing the company's CEO, José Manuel Santamaría Perez. Oncostellae, based in Ourense and tied to researchers and professors from the University of Santiago, is confident that the investment made in January 2016 by Catalan venture capital fund, Inveready Capital, will be a gateway for new funding, through venture capital funds and government grants.
(content in spanish)
Oncostellae prepara la llegada de fondos especializados en biotecnología para financiar la fase preclínica de sus fármacos para el tratamiento de cánceres hematológicos y de próstata, según ha publicado el diario Expansión el 4 de marzo de 2016, basándose en declaraciones del administrador de la compañía, José Manuel Santamaría Pérez. Oncostellae, con sede en Ourense y ligada a investigadores y docentes de la Universidade de Santiago, confía en que la operación de entrada en enero de 2016 del fondo de capital riesgo catalán, Inveready Capital, actúe como puerta de entrada para nuevas vías de financiación, a través de fondos de capital riesgo y de ayudas y subvenciones oficiales. |
|
Intel ID | 234440 | |
Value | ND | |
Native Currency | Euro (EUR) | |
Financial Data - Oncostellae
(31 Dec 2021) |
Revenue: - Net Debt: - People: 8 |
|
Date |
![]() |
|
Country | ![]() |
|
Region | ||
Continent | ![]() |
|
Geography | ![]() |
|
Subsector (Old TTR Sectors) |
|
|
Type |
![]() |
|
Intel Grade |
![]() |
|
Source |
![]() |
|
Tags | ![]() |
Target
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.